Onsior Injection is a drug owned by ELANCO US INC. It is protected by 2 US drug patents filed from 2018 to 2021. All patents have expired. Details of Onsior Injection’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6310099 | 25 Aug, 2018 | Expired |
Exclusivity Information
Onsior Injection holds 1 exclusivity out of which 1 has expired. Details of Onsior Injection's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Aug 05, 2018 |
About Onsior Injection
Onsior Injection is a drug
owned by ELANCO US INC.
Onsior Injection uses
Robenacoxib as the active
ingredient.
Active Ingredient:
Onsior Injection uses
Robenacoxib as the active ingredient.
Check out other Drugs and Companies using
Robenacoxib ingredient.